Antibody humanization by structure-based computational protein design

References

• Brooks M. Top 100 selling drugs of 2013. Medscape Medical News, 2014. Available at http://www.medscape.com/viewarticle/820011
   Google Scholar
• Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343-57; PMID:16622479; http://dx.doi.org/10.1038/nri1837
   PubMed Web of Science ®Google Scholar
• Jones PT, Dear PH, Foote J, Neuberger MS, Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986; 321:522–5; PMID:3713831
   Google Scholar
• Roguska MA, Pedersen JT, Keddy CA, Henry AH, Searle SJ, Lambert JM, Goldmacher VS, Blättler WA, Rees AR, Guild BC. Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc Natl Acad Sci 1994; 91:969-73; PMID:8302875
   PubMed Web of Science ®Google Scholar
• Gonzales NR, Padlan EA, De Pascalis R, Schuck P, Schlom J, Kashmiri SV. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity. Mol Immunol 2004; 41:863-72; PMID:15261458; http://dx.doi.org/10.1016/j.molimm.2004.03.041
   PubMed Web of Science ®Google Scholar
• Khee Hwang WY, Almagro JC, Buss TN, Tan P, Foote J. Use of human germline genes in a CDR homology-based approach to antibody humanization. Methods 2005; 36:35-42; PMID:15848073; http://dx.doi.org/10.1016/j.ymeth.2005.01.004
   PubMed Web of Science ®Google Scholar
• Lazar GA, Desjarlais JR, Jacinto J, Karki S, Hammond PW. A molecular immunology approach to antibody humanization and functional optimization. Mol Immunol 2007; 44:1986-98; PMID:17079018; http://dx.doi.org/10.1016/j.molimm.2006.09.029
   PubMed Web of Science ®Google Scholar
• Baca M, Presta LG, O'Connor SJ, Wells JA. Antibody humanization using monovalent phage display. J Biol Chem 1997; 272:10678-84; PMID:9099717; http://dx.doi.org/10.1074/jbc.272.16.10678
   PubMed Web of Science ®Google Scholar
• Dall'Acqua WF, Damschroder MM, Zhang J, Woods RM, Widjaja L, Yu J, Wu H. Antibody humanization by framework shuffling. Methods 2005; 36:43-60; PMID:15848074; http://dx.doi.org/10.1016/j.ymeth.2005.01.005
   PubMedGoogle Scholar
• Dennis MS. CDR repair: A novel approach to antibody humanization. In Shire SJ, Gombotz W, Bechtold-Peters K, Andya J (Eds.), Current Trends in Monoclonal Antibody Development and Manufacturing. New York: Springer-Verlag, 2010; 9-28.
   Google Scholar
• Osbourn J, Groves M, Vaughan T. From rodent reagents to human therapeutics using antibody guided selection. Methods 2005; 36:61-8; PMID:15848075; http://dx.doi.org/10.1016/j.ymeth.2005.01.006
   PubMed Web of Science ®Google Scholar
• Hwang WYK, Foote J. Immunogenicity of engineered antibodies. Methods 2005; 36:3-10; PMID:15848070; http://dx.doi.org/10.1016/j.ymeth.2005.01.001
   PubMed Web of Science ®Google Scholar
• McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nat 1990; 348:552-4; PMID:2247164; http://dx.doi.org/10.1038/348552a0
   PubMed Web of Science ®Google Scholar
• Feldhaus MJ, Siegel RW, Opresko LK, Coleman JR, Feldhaus JMW, Yeung YA, Cochran JR, Heinzelman P, Colby D, Swers J, et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat Biotechnol 2003; 21:163-70; PMID:12536217; http://dx.doi.org/10.1038/nbt785
   PubMed Web of Science ®Google Scholar
• Lee E-C, Liang Q, Ali H, Bayliss L, Beasley A, Bloomfield-Gerdes T, Bonoli L, Brown R, Campbell J, Carpenter A, et al. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery. Nat Biotechnol 2014; 32:356-63; PMID:24633243; http://dx.doi.org/10.1038/nbt.2825
   PubMed Web of Science ®Google Scholar
• Lonberg N. In Chernajovsky Y, Nissim A (Eds.), Human monoclonal antibodies from transgenic mice. Therapeutic Antibodies. Berlin: Springer-Verlag; 2008; 69-97.
   Google Scholar
• Duvall M, Bradley N, Fiorini RN. A novel platform to produce human monoclonal antibodies: The next generation of therapeutic human monoclonal antibodies discovery. mAbs 2011; 3(2):203-8; PMID:21285537
   PubMed Web of Science ®Google Scholar
• Li J, Sai T, Berger M, Chao Q, Davidson D, Deshmukh G, Drozdowski B, Ebel W, Harley S, Henry M, et al. Human antibodies for immunotherapy development generated via a human B cell hybridoma technology. Proc Natl Acad Sci U S A 2006; 103:3557-62; PMID:16505368; http://dx.doi.org/10.1073/pnas.0511285103
   PubMed Web of Science ®Google Scholar
• Clark M. Antibody humanization: a case of the ‘Emperor's new clothes’? Immunology Today 2000; 21:397-402; PMID:10916143; http://dx.doi.org/10.1016/S0167-5699(00)01680-7
   PubMedGoogle Scholar
• Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ. The safety and side effects of monoclonal antibodies. Nat Rev Drug Dis 2010; 9:325-38; PMID:20305665; http://dx.doi.org/10.1038/nrd3003
   PubMed Web of Science ®Google Scholar
• Almagro JC, Fransson J. Humanization of antibodies. Front Biosci 2008; 13:1619-33; PMID:17981654
   PubMed Web of Science ®Google Scholar
• Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Dis 2010; 9:767-74; PMID:20811384; http://dx.doi.org/10.1038/nrd3229
   PubMed Web of Science ®Google Scholar
• Lu Z-J, Deng S-J, Huang D-G, He Y, Lei M, Zhou L, Jin P. Frontier of therapeutic antibody discovery: the challenges and how to face them. World J Biol Chem 2012; 3:187; PMID:23275803; http://dx.doi.org/10.4331/wjbc.v3.i12.187
   PubMedGoogle Scholar
• Bogen B, Ruffini P. Review: to what extent are T cells tolerant to immunoglobulin variable regions? Scandinavian J Immunol 2009; 70:526-30; PMID:19906193; http://dx.doi.org/10.1111/j.1365-3083.2009.02340.x
   PubMed Web of Science ®Google Scholar
• Chames P, Van Regenmortel M, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 2009; 157:220-33; PMID:19459844; http://dx.doi.org/10.1111/j.1476-5381.2009.00190.x
   PubMed Web of Science ®Google Scholar
• Pavlinkova G, Colcher D, Booth BJ, Goel A, Wittel UA, Batra SK. Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-tag-72 single-chain Fvs. Inter J Cancer 2001; 94:717-26; PMID:11745468; http://dx.doi.org/10.1002/ijc.1523
   PubMed Web of Science ®Google Scholar
• Jawa V, Cousens LP, Awwad M, Wakshull E, Kropshofer H, De Groot AS. T-cell dependent immunogenicity of protein therapeutics: preclinical assessment and mitigation. Clin Immunol 2013; 149:534-55; PMID:24263283; http://dx.doi.org/10.1016/j.clim.2013.09.006
   PubMed Web of Science ®Google Scholar
• Marcatili P, Rosi A, Tramontano A. PIGS: automatic prediction of antibody structures. Bioinformatics 2008; 24:1953-4; PMID:18641403; http://dx.doi.org/10.1093/bioinformatics/btn341
   PubMed Web of Science ®Google Scholar
• Shirai H, Ikeda K, Yamashita K, Tsuchiya Y, Sarmiento J, Liang S, Morokata T, Mizuguchi K, Higo J, Standley DM, et al. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations. Proteins 2014; 82:1624-35; PMID:24756852
   PubMed Web of Science ®Google Scholar
• Sivasubramanian A, Sircar A, Chaudhury S, Gray JJ. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins 2009; 74:497-514; PMID:19062174; http://dx.doi.org/10.1002/prot.22309
   PubMed Web of Science ®Google Scholar
• Zhu K, Day T, Warshaviak D, Murrett C, Friesner R, Pearlman D. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction. Proteins 2014; 82:1646-55; PMID:24619874
   PubMed Web of Science ®Google Scholar
• Choi Y, Deane CM. Predicting antibody complementarity determining region structures without classification. Mol Biosys 2011; 7:3327-34; PMID:22011953; http://dx.doi.org/10.1039/c1mb05223c
   PubMed Web of Science ®Google Scholar
• North B, Lehmann A, Dunbrack Jr RL. A new clustering of antibody CDR loop conformations. J Mol Biol 2011; 406:228-56; PMID:21035459; http://dx.doi.org/10.1016/j.jmb.2010.10.030
   PubMed Web of Science ®Google Scholar
• Weitzner BD, Kuroda D, Marze N, Xu J, Gray JJ. Blind prediction performance of RosettaAntibody 3.0: Grafting, relaxation, kinematic loop modeling, and full CDR optimization. Proteins 2014; 82:1611-23; PMID:24519881; http://dx.doi.org/10.1002/prot.24534
   PubMed Web of Science ®Google Scholar
• Damborsky J, Brezovsky J. Computational tools for designing and engineering enzymes. Curr Opin Chem Biol 2014; 19:8-16; PMID:24780274; http://dx.doi.org/10.1016/j.cbpa.2013.12.003
   PubMed Web of Science ®Google Scholar
• Kazlauskas RJ, Bornscheuer UT. Finding better protein engineering strategies. Nat Chem Biol 2009; 5:526-9; PMID:19620988; http://dx.doi.org/10.1038/nchembio0809-526
   PubMed Web of Science ®Google Scholar
• Kries H, Blomberg R, Hilvert D. De novo enzymes by computational design. Curr Opin Chem Biol 2013; 17:221-8; PMID:23498973; http://dx.doi.org/10.1016/j.cbpa.2013.02.012
   PubMed Web of Science ®Google Scholar
• Dunbar J, Fuchs A, Shi J, Deane C. ABangle: characterising the VH-VL orientation in antibodies. Protein Engineering Design and Selection 2013; 26:611-20; http://dx.doi.org/10.1093/protein/gzt020
   PubMed Web of Science ®Google Scholar
• Kunik V, Ashkenazi S, Ofran Y. Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure. Nucl Acids Res 2012; 40:W521-W4; PMID:22675071; http://dx.doi.org/10.1093/nar/gks480
   PubMedGoogle Scholar
• Olimpieri PP, Chailyan A, Tramontano A, Marcatili P. Prediction of site-specific interactions in antibody-antigen complexes: the proABC method and server. Bioinformatics 2013; 29:2285-91; PMID:23803466
   PubMed Web of Science ®Google Scholar
• Olimpieri PP, Marcatili P, Tramontano A. Tabhu: Tools for antibody humanization. Bioinformatics 2015; 31:434-5; PMID:25304777
   PubMed Web of Science ®Google Scholar
• Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE, DeBolt S, Ferguson D, Seibel G, Kollman P. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun 1995; 91:1-41; http://dx.doi.org/10.1016/0010-4655(95)00041-D
   Web of Science ®Google Scholar
• Parker AS, Choi Y, Griswold KE, Bailey-Kellogg C. Structure-guided deimmunization of therapeutic proteins. J Comput Biol 2013; 20:152-65; PMID:23384000; http://dx.doi.org/10.1089/cmb.2012.0251
   PubMed Web of Science ®Google Scholar
• Zhang T, Wu M-R, Sentman CL. An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo. J Immunol 2012; 189:2290-9; PMID:22851709; http://dx.doi.org/10.4049/jimmunol.1103495
   PubMed Web of Science ®Google Scholar
• Rammensee H-G, Friede T, Stevanović S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41:178-228; PMID:7890324; http://dx.doi.org/10.1007/BF00172063
   PubMed Web of Science ®Google Scholar
• Ehrenmann F, Lefranc M-P. IMGT/3Dstructure-DB: querying the IMGT database for 3D structures in immunology and immunoinformatics (IG or antibodies, TR, MH, RPI, and FPIA). Cold Spring Harbor Protocols 2011; 2011:750-61 pdb-prot5637
   PubMedGoogle Scholar
• Poiron C, Wu Y, Ginestoux C, Ehrenmann F, Patrice D, Lefranc M-P. IMGT/mAb-DB: the IMGT database for therapeutic monoclonal antibodies. JOBIM 2010; 13
   Google Scholar
• Giudicelli V, Chaume D, Lefranc M-P. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucl Acids Res 2004; 32:W435-W40; PMID:15215425; http://dx.doi.org/10.1093/nar/gkh412
   PubMed Web of Science ®Google Scholar
• Retter I, Althaus HH, Munch R, Muller W. VBASE2, an integrative V gene database. Nucl Acids Res 2005; 33:D671-D4; PMID:15608286; http://dx.doi.org/10.1093/nar/gki088
   PubMed Web of Science ®Google Scholar
• Tomlinson I, Williams S, Corbett S, Cox J, Winter G. V BASE sequence directory. Cambridge, UK: MRC Centre for protein engineering; 1996.
   Google Scholar
• Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10; PMID:2231712; http://dx.doi.org/10.1016/S0022-2836(05)80360-2
   PubMed Web of Science ®Google Scholar
• Narayanan A, Sellers BD, Jacobson MP. Energy-based analysis and prediction of the orientation between light-and heavy-chain antibody variable domains. J Mol Biol 2009; 388:941-53; PMID:19324053; http://dx.doi.org/10.1016/j.jmb.2009.03.043
   PubMed Web of Science ®Google Scholar
• Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol 1992; 224:487-99; PMID:1560463; http://dx.doi.org/10.1016/0022-2836(92)91010-M
   PubMed Web of Science ®Google Scholar
• Safdari Y, Farajnia S, Asgharzadeh M, Khalili M. Antibody humanization methods-a review and update. Biotechnol Genet Eng Rev 2013; 29:175-86; PMID:24568279; http://dx.doi.org/10.1080/02648725.2013.801235
   PubMed Web of Science ®Google Scholar
• Abhinandan K, Martin AC. Analyzing the “degree of humanness” of antibody sequences. J Mol Biol 2007; 369:852-62; PMID:17442342; http://dx.doi.org/10.1016/j.jmb.2007.02.100
   PubMed Web of Science ®Google Scholar
• Gao SH, Huang K, Tu H, Adler AS. Monoclonal antibody humanness score and its applications. BMC Biotechnol 2013; 13:55; PMID:23826749; http://dx.doi.org/10.1186/1472-6750-13-55
   PubMed Web of Science ®Google Scholar
• Thullier P, Huish O, Pelat T, Martin AC. The humanness of macaque antibody sequences. J Mol Biol 2010; 396:1439-50; PMID:20043919; http://dx.doi.org/10.1016/j.jmb.2009.12.041
   PubMed Web of Science ®Google Scholar
• Harding FA, Stickler MM, Razo J, DuBridge RB. The immunogenicity of humanized and fully human antibodies. MAbs 2010; 2:256-65; PMID:20400861
   PubMed Web of Science ®Google Scholar
• King C, Garza EN, Mazor R, Linehan JL, Pastan I, Pepper M, Baker D. Removing T-cell epitopes with computational protein design. Proc Natl Acad Sci 2014; 111:8577-82; PMID:24843166; http://dx.doi.org/10.1073/pnas.1321126111
   PubMed Web of Science ®Google Scholar
• Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, Lee EC, Kreitman RJ, Lee B, Baker D, et al. Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Proc Natl Acad Sci 2014; 111:8571-6; PMID:24799704; http://dx.doi.org/10.1073/pnas.1405153111
   PubMed Web of Science ®Google Scholar
• Salvat RS, Choi Y, Bishop A, Bailey-Kellogg C, Griswold KE. Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads. Biotechnol Bioeng 2015; PMID:25655032
   PubMed Web of Science ®Google Scholar
• Salvat RS, Parker AS, Choi Y, Bailey-Kellogg C, Griswold KE. Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate. PLoS Comput Biol 2015; 11:e1003988; PMID:25568954; http://dx.doi.org/10.1371/journal.pcbi.1003988
   PubMedGoogle Scholar
• Salvat RS, Parker AS, Guilliams A, Choi Y, Bailey-Kellogg C, Griswold KE. Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate. Cell Mol Life Sci 2014; 71:4869-80; PMID:24880662; http://dx.doi.org/10.1007/s00018-014-1652-x
   PubMed Web of Science ®Google Scholar
• Kumar A, Blum KA, Fung HC, Smith MR, Foster PA, Younes A. A phase 1 dose-escalation study of XmAb® 2513 in patients with relapsed or refractory Hodgkin lymphoma. Br J Haematol 2014; PMID:AMBIGUOUS
   PubMedGoogle Scholar
• Parham P, Ohta T. Population biology of antigen presentation by MHC class I molecules. Science 1996; 272:67-74; PMID:8600539; http://dx.doi.org/10.1126/science.272.5258.67
   PubMed Web of Science ®Google Scholar
• Reche PA, Reinherz EL. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 2003; 331:623-41; PMID:12899833; http://dx.doi.org/10.1016/S0022-2836(03)00750-2
   PubMed Web of Science ®Google Scholar
• Lovell SC, Word JM, Richardson JS, Richardson DC. The penultimate rotamer library. Proteins 2000; 40:389-408; PMID:10861930; http://dx.doi.org/10.1002/1097-0134(20000815)40:3%3c389::AID-PROT50%3e3.0.CO;2-2
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Georgiev I, Anderson AC, Donald BR. Computational structure-based redesign of enzyme activity. Proc Natl Acad Sci 2009; 106:3764-9; PMID:19228942; http://dx.doi.org/10.1073/pnas.0900266106
   PubMed Web of Science ®Google Scholar
• Gainza P, Roberts KE, Donald BR. Protein design using continuous rotamers. PLoS Comput Biol 2012; 8:e1002335; PMID:22279426; http://dx.doi.org/10.1371/journal.pcbi.1002335
   PubMed Web of Science ®Google Scholar
• Goldstein RF. Efficient rotamer elimination applied to protein side-chains and related spin glasses. Biophys J 1994; 66:1335-40; PMID:8061189; http://dx.doi.org/10.1016/S0006-3495(94)80923-3
   PubMed Web of Science ®Google Scholar
• Abhinandan K, Martin AC. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. Mol Immunol 2008; 45:3832-9; PMID:18614234; http://dx.doi.org/10.1016/j.molimm.2008.05.022
   PubMed Web of Science ®Google Scholar
• He L, Friedman AM, Bailey-Kellogg C. A divide-and-conquer approach to determine the Pareto frontier for optimization of protein engineering experiments. Proteins 2012; 80:790-806; PMID:22180081; http://dx.doi.org/10.1002/prot.23237
   PubMed Web of Science ®Google Scholar
• Krivov GG, Shapovalov MV, Dunbrack RL. Improved prediction of protein side-chain conformations with SCWRL4. Proteins 2009; 77:778-95; PMID:19603484; http://dx.doi.org/10.1002/prot.22488
   PubMed Web of Science ®Google Scholar
• Choi Y, Deane CM. FREAD revisited: accurate loop structure prediction using a database search algorithm. Proteins 2010; 78:1431-40; PMID:20034110
   PubMed Web of Science ®Google Scholar
• Kelm S, Vangone A, Choi Y, Ebejer J-P, Shi J, Deane CM. Fragment-based modeling of membrane protein loops: Successes, failures, and prospects for the future. Proteins 2014; 82:175-86; PMID:23589399; http://dx.doi.org/10.1002/prot.24299
   PubMed Web of Science ®Google Scholar
• Ponder JW. TINKER: Software tools for molecular design (Ver. 6.0). Saint Louis, MO: Washington University School of Medicine; 2004; 3.
   Google Scholar
• Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006; 65:712-25; PMID:16981200; http://dx.doi.org/10.1002/prot.21123
   PubMed Web of Science ®Google Scholar
• Qiu D, Shenkin PS, Hollinger FP, Still WC. The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii. J Phys Chem 1997; 101:3005-14; http://dx.doi.org/10.1021/jp961992r
   Web of Science ®Google Scholar
• Eswar N, Webb B, Marti-Renom MA, Madhusudhan M, Eramian D, Shen M-Y, Pieper U, Sali A. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformat 2006:5-6; PMID:18428767
   PubMedGoogle Scholar
• Shen M-y, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci 2006; 15:2507-24; PMID:17075131; http://dx.doi.org/10.1110/ps.062416606
   PubMed Web of Science ®Google Scholar
• Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 1997; 273:927-48; PMID:9367782; http://dx.doi.org/10.1006/jmbi.1997.1354
   PubMed Web of Science ®Google Scholar
• Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987; 196:901-17; PMID:3681981; http://dx.doi.org/10.1016/0022-2836(87)90412-8
   PubMed Web of Science ®Google Scholar
• Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, et al. Conformations of immunoglobulin hypervariable regions. Nature 1989; 342:877-83; PMID:2687698; http://dx.doi.org/10.1038/342877a0
   PubMed Web of Science ®Google Scholar
• Deane CM, Blundell TL. CODA: a combined algorithm for predicting the structurally variable regions of protein models. Protein Sci 2001; 10:599-612; PMID:11344328; http://dx.doi.org/10.1110/ps.37601
   PubMed Web of Science ®Google Scholar
• Boesch AW, Brown EP, Cheng HD, Ofori MO, Normandin E, Nigrovic PA, Alter G, Ackerman ME. Highly parallel characterization of IgG Fc binding interactions. mAbs 2014; 6(4):915-27; PMID:24927273; http://dx.doi.org/10.4161/mabs.28808
   PubMed Web of Science ®Google Scholar